China permits Indian students to return on 'need-assessed' basis
Darpan News Desk IANS, 29 Apr, 2022 12:10 PM
New Delhi, April 29 (IANS) China has allowed return of Indian students to its various universities on a "need-assessed basis", according to the Indian Embassy in China.
According to the Embassy, following the meeting of External Affairs Minister S. Jaishankar with his Chinese counterpart Wang Yi on March 25, the Chinese side has expressed its willingness to consider facilitating the return of Indian students to China on a need-assessed basis.
In order to facilitate this, the Indian Embassy intends to prepare a list of such students which will be shared with the Chinese side for their consideration.
The embassy has come up with a form and requested Indian students to fill out citing their necessity.
Once the collated information is shared with the Chinese side, it would consult relevant Chinese departments and varsities to verify the list and indicate whether the identified students can travel to China to complete the course.
This coordination process would be carried out in a time-bound manner.
The Chinese side has also conveyed that eligible students should unconditionally abide by Covid-19 prevention measures, and agree to bear all expenses related to Covid-19 prevention measures by themselves.
Over 23,000 Indian students, primarily studying medicines, are stuck back home due to Covid-19 visas and flight bans by China in attempt to control spread of Covid-19.
Many Indian Americans are wracked with guilt over emerging from more than a year of isolation as relatives overseas struggle to find vaccines, hospital beds and, fatefully, their breath.
Many of the 64 people affected either fainted or reported dizziness. Some got nauseous or vomited, and a few had racing hearts, chest pain or other symptoms.
In a statement Friday, the two pharmaceuticals said their submission to the European Medicines Agency is based on an advanced study in more than 2,000 adolescents that showed their vaccine to be safe and effective.
In the same breath, however, the speech marking Biden's first 100 days as commander-in-chief offered a measure of comfort by suggesting Buy American would not offend the terms of trade deals like the U.S.-Mexico-Canada Agreement.
So far, Pfizer's ongoing trial indicates the company's two-dose vaccine remains highly effective for at least six months, and likely longer. People who got Moderna’s vaccine also still had notable levels of virus-fighting antibodies six months after the second required shot.
